Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/31/2026

Two‑Dose Albendazole Regimen for Pinworm (Enterobiasis) Infection

Pharmacology and Parasite Life‑Cycle

  • Adult Enterobius worms require several days to weeks to be eliminated from the gastrointestinal tract after effective albendazole therapy, reflecting the drug’s gradual depletion of parasite energy stores. [1][2]
  • Albendazole’s ovicidal activity does not instantly destroy eggs already deposited in the perianal area; residual eggs may continue to cause pruritus for several days after the first dose. [1][2]

Rationale for a Two‑Dose Schedule

  • The standard regimen (initial dose followed by a repeat dose 2 weeks later) is specifically designed to cover the pinworm life cycle, because the first dose may not eradicate all developmental stages, including newly hatched larvae from surviving eggs. [1][2]3
  • The second dose is critical for targeting larvae that hatch after the first treatment, ensuring complete eradication of the infection. [1][2]
  • First dose: 400 mg albendazole administered as a single oral dose.
  • Second dose: Repeat 400 mg dose given approximately 2 weeks (≈12 days) after the first dose. This interval aligns with the parasite’s pre‑patent period of 2–6 weeks. [1][2]3
  • The same 400 mg single‑dose regimen is appropriate for young children (e.g., a 4‑year‑old) when weight‑based dosing is considered. [1][2]

Guideline Endorsements

  • The United Kingdom clinical guidelines recommend albendazole 400 mg with a repeat dose in 2 weeks for the treatment of threadworm infection. 3

Timing and Interval Considerations

  • A 2‑week interval between doses matches the pinworm pre‑patent period (2–6 weeks), optimizing the chance of killing newly emerged larvae. 2
  • Administering additional doses at intervals shorter than 2 weeks does not improve efficacy and deviates from the standard protocol. [1][2]3

Diagnostic Confirmation (if needed)

  • Treatment success can be verified with the cellophane‑tape (Graham‑Scotch) test performed on three consecutive mornings after the regimen is completed. 1

Interpretation of Early Persistent Symptoms

  • Persistent perianal itching 2–3 days after the first albendazole dose is expected and does not indicate treatment failure; the full two‑dose course should be completed as scheduled. [1][2]